Palatin Technologies Inc (PTN)
1.71
-0.02
(-1.16%)
USD |
NYAM |
Apr 25, 16:00
1.71
0.00 (0.00%)
After-Hours: 17:17
Palatin Technologies Enterprise Value: 18.43M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 18.43M |
| April 23, 2024 | 18.75M |
| April 22, 2024 | 18.27M |
| April 19, 2024 | 20.21M |
| April 18, 2024 | 21.01M |
| April 17, 2024 | 21.17M |
| April 16, 2024 | 20.69M |
| April 15, 2024 | 19.88M |
| April 12, 2024 | 21.50M |
| April 11, 2024 | 22.79M |
| April 10, 2024 | 20.69M |
| April 09, 2024 | 24.08M |
| April 08, 2024 | 23.11M |
| April 05, 2024 | 18.92M |
| April 04, 2024 | 18.59M |
| April 03, 2024 | 17.95M |
| April 02, 2024 | 18.27M |
| April 01, 2024 | 18.92M |
| March 28, 2024 | 20.69M |
| March 27, 2024 | 16.33M |
| March 26, 2024 | 16.66M |
| March 25, 2024 | 15.04M |
| March 22, 2024 | 15.53M |
| March 21, 2024 | 16.66M |
| March 20, 2024 | 15.85M |
| Date | Value |
|---|---|
| March 19, 2024 | 15.69M |
| March 18, 2024 | 16.33M |
| March 15, 2024 | 15.37M |
| March 14, 2024 | 14.72M |
| March 13, 2024 | 16.33M |
| March 12, 2024 | 17.46M |
| March 11, 2024 | 18.11M |
| March 08, 2024 | 20.21M |
| March 07, 2024 | 21.01M |
| March 06, 2024 | 20.53M |
| March 05, 2024 | 22.30M |
| March 04, 2024 | 22.47M |
| March 01, 2024 | 26.02M |
| February 29, 2024 | 22.95M |
| February 28, 2024 | 30.05M |
| February 27, 2024 | 54.58M |
| February 26, 2024 | 48.93M |
| February 23, 2024 | 41.02M |
| February 22, 2024 | 41.99M |
| February 21, 2024 | 38.60M |
| February 20, 2024 | 42.80M |
| February 16, 2024 | 39.25M |
| February 15, 2024 | 41.35M |
| February 14, 2024 | 57.32M |
| February 13, 2024 | 54.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.910M
Minimum
Mar 18 2020
314.54M
Maximum
May 16 2019
56.09M
Average
41.53M
Median
Oct 11 2021
Enterprise Value Benchmarks
| Oragenics Inc | 3.306M |
| Outset Medical Inc | 55.58M |
| Ligand Pharmaceuticals Inc | 1.087B |
| Galectin Therapeutics Inc | 251.97M |
| ADMA Biologics Inc | 1.554B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.844M |
| Revenue (Quarterly) | 2.034M |
| Total Expenses (Quarterly) | 8.684M |
| EPS Diluted (Quarterly) | -0.56 |
| Gross Profit Margin (Quarterly) | 95.20% |
| Profit Margin (Quarterly) | -385.6% |
| Earnings Yield | -152.6% |
| Normalized Earnings Yield | -147.89 |